Business Description
Sichuan Zitonggong Pharmaceutical Co Ltd
ISIN : CNE100004MP0
Compare
Compare
Traded in other countries / regions
832566.China IPO Date
2021-08-13Description
Sichuan Zitonggong Pharmaceutical Co Ltd is a high-tech enterprise focusing on the R&D, production, and marketing of tablets, hard capsules, liniments, powders, and ointments. It has developed a number of drug varieties such as Citicoline Sodium Tablets and Rizatriptan Benzoate Capsules.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 27.42 | |||||
| Equity-to-Asset | 0.83 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.11 | |||||
| Interest Coverage | 333.52 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 6.93 | |||||
| Beneish M-Score | -2.38 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5.1 | |||||
| 3-Year EBITDA Growth Rate | 3.9 | |||||
| 3-Year EPS without NRI Growth Rate | 7.3 | |||||
| 3-Year FCF Growth Rate | 38.8 | |||||
| 3-Year Book Growth Rate | 15.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.09 | |||||
| 9-Day RSI | 35.97 | |||||
| 14-Day RSI | 38.57 | |||||
| 6-1 Month Momentum % | -3.5 | |||||
| 12-1 Month Momentum % | 13.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.28 | |||||
| Quick Ratio | 5.77 | |||||
| Cash Ratio | 4.26 | |||||
| Days Inventory | 201.44 | |||||
| Days Sales Outstanding | 94.32 | |||||
| Days Payable | 105.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.88 | |||||
| Dividend Payout Ratio | 0.42 | |||||
| Forward Dividend Yield % | 4.52 | |||||
| 5-Year Yield-on-Cost % | 3.97 | |||||
| 3-Year Average Share Buyback Ratio | -8.8 | |||||
| Shareholder Yield % | 3.51 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 81.08 | |||||
| Operating Margin % | 27.57 | |||||
| Net Margin % | 25.78 | |||||
| FCF Margin % | 19.04 | |||||
| ROE % | 14.41 | |||||
| ROA % | 12.11 | |||||
| ROIC % | 23.55 | |||||
| ROC (Joel Greenblatt) % | 62.59 | |||||
| ROCE % | 15.26 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 10.91 | |||||
| PE Ratio without NRI | 10.93 | |||||
| Shiller PE Ratio | 17.16 | |||||
| Price-to-Owner-Earnings | 14.41 | |||||
| PEG Ratio | 1.18 | |||||
| PS Ratio | 2.82 | |||||
| PB Ratio | 1.48 | |||||
| Price-to-Tangible-Book | 1.81 | |||||
| Price-to-Free-Cash-Flow | 14.72 | |||||
| Price-to-Operating-Cash-Flow | 10.84 | |||||
| EV-to-EBIT | 6.95 | |||||
| EV-to-EBITDA | 6.95 | |||||
| EV-to-Revenue | 2.05 | |||||
| EV-to-FCF | 10.79 | |||||
| Price-to-Projected-FCF | 1 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.08 | |||||
| Price-to-Graham-Number | 0.94 | |||||
| Price-to-Net-Current-Asset-Value | 3.07 | |||||
| Price-to-Net-Cash | 5.65 | |||||
| Earnings Yield (Greenblatt) % | 14.39 | |||||
| FCF Yield % | 6.9 | |||||
| Forward Rate of Return (Yacktman) % | 15.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sichuan Zitonggong Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 411.315 | ||
| EPS (TTM) (Â¥) | 0.71 | ||
| Beta | 0 | ||
| Volatility % | 47.42 | ||
| 14-Day RSI | 38.57 | ||
| 14-Day ATR (Â¥) | 0.201558 | ||
| 20-Day SMA (Â¥) | 8.139 | ||
| 12-1 Month Momentum % | 13.15 | ||
| 52-Week Range (Â¥) | 5.72 - 10.98 | ||
| Shares Outstanding (Mil) | 146.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sichuan Zitonggong Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sichuan Zitonggong Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sichuan Zitonggong Pharmaceutical Co Ltd Frequently Asked Questions
What is Sichuan Zitonggong Pharmaceutical Co Ltd(BJSE:832566)'s stock price today?
The current price of BJSE:832566 is ¥7.74. The 52 week high of BJSE:832566 is ¥10.98 and 52 week low is ¥5.72.
When is next earnings date of Sichuan Zitonggong Pharmaceutical Co Ltd(BJSE:832566)?
The next earnings date of Sichuan Zitonggong Pharmaceutical Co Ltd(BJSE:832566) is .
Does Sichuan Zitonggong Pharmaceutical Co Ltd(BJSE:832566) pay dividends? If so, how much?
The Dividend Yield %  of Sichuan Zitonggong Pharmaceutical Co Ltd(BJSE:832566) is 3.88% (As of Today), Highest Dividend Payout Ratio of Sichuan Zitonggong Pharmaceutical Co Ltd(BJSE:832566) was 0.81. The lowest was 0.23. And the median was 0.44. The  Forward Dividend Yield % of Sichuan Zitonggong Pharmaceutical Co Ltd(BJSE:832566) is 4.52%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers